Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice

British Journal of Nutrition

Volumn 114, Issue 8, 2015, Pages 1123-1131

  Farrell, Nicholas J ^a   Norris, Gregory H ^a   Ryan, Julia ^a   Porter, Caitlin M ^a   Jiang, Christina ^a   Blesso, Christopher N ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Black elderberry extract; Diet induced obese mice; Inflammation; Insulin resistance; Molecular nutrition; Obesity

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; ADIPOCYTE PROTEIN 2; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; BLACK ELDERBERRY EXTRACT; CD68 ANTIGEN; CELL PROTEIN; CHOLESTEROL; COLLAGEN TYPE 6; COLLAGEN TYPE 6 ALPHA3; FATTY ACID SYNTHASE; INSULIN; INTERLEUKIN 6; LIPOPROTEIN LIPASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLANT EXTRACT; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; FAT INTAKE; LARD; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ACOX GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAS GENE; FIBROSIS; GENE EXPRESSION; HISTOLOGY; HOMOEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID STORAGE; LIPOGENESIS; LIVER WEIGHT; LPL GENE; MACROPHAGE; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY; PPAR GAMMA2 GENE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TGF BETA GENE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FAT INTAKE; GENETICS; LIPID DIET; LIVER; LOW FAT DIET; METABOLISM; MOUSE MUTANT; SAMBUCUS NIGRA; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CHEMOKINE CCL2; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MUSCLE, SKELETAL; OBESITY; PLANT EXTRACTS; PPAR GAMMA; RNA, MESSENGER; SAMBUCUS NIGRA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84944151659     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515002962     Document Type: Article

References (38)

1. World Health Organization (2015) Obesity and overweight, fact sheet no. 311. http://www.who.int/mediacentre/factsheets/ fs311/en (accessed May 2015).
2. Peeters A, Barendregt JJ, Willekens F, et al. (2003) Obesity in adulthood and its consequences for life expectancy: a lifetable analysis. Ann Intern Med 138, 24-32.
3. Must A, Spadano J, Coakley EH, et al. (1999) The disease burden associated with overweight and obesity. JAMA 282, 1523-1529.
4. Haslam DW & James WP (2005) Obesity. Lancet 366, 1197-1209.
5. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860-867.
6. Guilherme A, Virbasius JV, Puri V, et al. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9, 367-377.
7. Jennings A, Welch AA, Spector T, et al. (2014) Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr 144, 202-208.
8. Guo H, Ling W, Wang Q, et al. (2008) Cyanidin 3-glucoside protects 3T3-L1 adipocytes against H2O2- or TNF-Alphainduced insulin resistance by inhibiting c-Jun NH2-Terminal kinase activation. Biochem Pharmacol 75, 1393-1401.
9. Guo H, Guo J, Jiang X, et al. (2012) Cyanidin-3-O-betaglucoside, a typical anthocyanin, exhibits antilipolytic effects in 3T3-L1 adipocytes during hyperglycemia: involvement of FoxO1-mediated transcription of adipose triglyceride lipase. Food Chem Toxicol 50, 3040-3047.
10. Scazzocchio B, Vari R, Filesi C, et al. (2011) Cyanidin-3-Obeta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes 60, 2234-2244.
11. Guo H, Xia M, Zou T, et al. (2012) Cyanidin 3-glucoside attenuates obesity-Associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. J Nutr Biochem 23, 349-360.
12. Sasaki R, Nishimura N, Hoshino H, et al. (2007) Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to down-regulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 74, 1619-1627.
13. Tang X, Shen T, Jiang X, et al. (2015) Purified anthocyanins from bilberry and black currant attenuate hepatic mitochondrial dysfunction and steatohepatitis in mice with methionine and choline deficiency. J Agric Food Chem 63, 552-561.
14. Karlsen A, Retterstol L, Laake P, et al. (2007) Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 137, 1951-1954.
15. Zhu Y, Ling W, Guo H, et al. (2013) Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial. Nutr Metab Cardiovasc Dis 23, 843-849.
16. Perez-Jimenez J, Neveu V, Vos F, et al. (2010) Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J Agric Food Chem 58, 4959-4969.
17. Wu X, Gu L, Prior RL, et al. (2004) Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity. J Agric Food Chem 52, 7846-7856.
18. Farrell N, Norris G, Lee SG, et al. (2015) Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice. Food Funct 6, 1278-1287.
19. Charlebois D, Byers P, Finn C, et al. (2010) Elderberry: botany, horticulture, potential. Hortic Rev (Am Soc Hortic Sci) 37, 213-280.
20. Wu X, Beecher GR, Holden JM, et al. (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54, 4069-4075.
21. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
22. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242SS.
23. Lotito SB & Frei B (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?. Free Radic Biol Med 41, 1727-1746.
24. Czank C, Cassidy A, Zhang Q, et al. (2013) Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-Tracer study. Am J Clin Nutr 97, 995-1003.
25. Vitaglione P, Donnarumma G, Napolitano A, et al. (2007) Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J Nutr 137, 2043-2048.
26. Bouhlel MA, Derudas B, Rigamonti E, et al. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6, 137-143.
27. Spencer M, Yao-Borengasser A, Unal R, et al. (2010) Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab 299, E1016-E1027.
28. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120.
29. Song E, Ouyang N, Horbelt M, et al. (2000) Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 204, 19-28.
30. Verrecchia F, Chu ML & Mauviel A (2001) Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276, 17058-17062.
31. Patsouris D, Cao JJ, Vial G, et al. (2014) Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans. PLOS ONE 9, e110653.
32. Munoz-Canoves P, Scheele C, Pedersen BK, et al. (2013) Interleukin-6 myokine signaling in skeletal muscle: a doubleedged sword?. FEBS J 280, 4131-4148.
33. Wallenius V, Wallenius K, Ahren B, et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8, 75-79.
34. Carey AL, Steinberg GR, Macaulay SL, et al. (2006) Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-Activated protein kinase. Diabetes 55, 2688-2697.
35. Glund S, Deshmukh A, Long YC, et al. (2007) Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 56, 1630-1637.
36. Shulman GI, Rothman DL, Jue T, et al. (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322, 223-228.
37. DeFuria J, Bennett G, Strissel KJ, et al. (2009) Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr 139, 1510-1516.
38. Chuang CC, Shen W, Chen H, et al. (2012) Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice. J Agric Food Chem 60, 12458-12468.